透過您的圖書館登入
IP:18.188.146.77
  • 期刊

Infliximab Preferentially Induces Clinical Remission and Mucosal Healing in Short Course Crohn’s Disease with Luminal Lesions through Balancing Abnormal Immune Response in Gut Mucosa

延伸閱讀